Literature DB >> 16299287

Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12.

Pu Feng1, Qiana M Wilson, Joseph J Meissler, Martin W Adler, Toby K Eisenstein.   

Abstract

We have shown previously that withdrawal from morphine induces immunosuppression in mice. The present study reports the effects of morphine withdrawal on infection with Salmonella enterica serovar Typhimurium. Mice were made dependent on morphine by the implantation of a slow-release morphine pellet for 96 h. Controls received a placebo pellet. Withdrawal was induced by pellet removal. Mice were inoculated intraperitoneally with Salmonella 24 h postwithdrawal. Morphine withdrawal sensitized mice to Salmonella infection, as evidenced by increased mortality, shortened mean survival time, and increased bacterial load in the blood, spleen, and liver. Examination of the levels of a panel of proinflammatory cytokines in sera of infected, morphine-withdrawn mice showed that morphine withdrawal inhibited the elevation of interleukin-12p70 (IL-12p70). The production of IL-12p40 in morphine withdrawal mice was also suppressed. The administration of exogenous IL-12 significantly decreased the bacterial burden in morphine-withdrawn mice. These studies show a correlation between the suppression of IL-12 production and a heightened susceptibility to Salmonella infection in mice undergoing withdrawal from morphine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299287      PMCID: PMC1307081          DOI: 10.1128/IAI.73.12.7953-7959.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Chronic morphine administration: plasma levels and withdrawal syndrome in rats.

Authors:  C Cerletti; S H Keinath; M M Reidenbery; M W Alder
Journal:  Pharmacol Biochem Behav       Date:  1976-03       Impact factor: 3.533

2.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

3.  Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

4.  Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12.

Authors:  Pu Feng; Joseph J Meissler; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmunol       Date:  2005-07       Impact factor: 3.478

5.  Disposition of morphine in chronically infused rats: relationship to antinociception and tolerance.

Authors:  G A Patrick; W L Dewey; F P Huger; E D Daves; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

6.  Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome.

Authors:  J B Glaser; L Morton-Kute; S R Berger; J Weber; F P Siegal; C Lopez; W Robbins; S H Landesman
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

7.  Salmonella infections in patients with the acquired immunodeficiency syndrome.

Authors:  J L Jacobs; J W Gold; H W Murray; R B Roberts; D Armstrong
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

8.  Effect of morphine on resistance to infection.

Authors:  E Tubaro; G Borelli; C Croce; G Cavallo; C Santiangeli
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

9.  Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection.

Authors:  T K Eisenstein; L M Killar; B M Sultzer
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

10.  Substance P levels in various regions of the rat central nervous system after acute and chronic morphine treatment.

Authors:  L Bergström; T Sakurada; L Terenius
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

View more
  12 in total

Review 1.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

2.  Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids.

Authors:  Subhas Das; Jennifer Kelschenbach; Richard Charboneau; Roderick A Barke; Sabita Roy
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

3.  Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut-derived sepsis in mice during chronic morphine administration.

Authors:  Trissa Babrowski; Christopher Holbrook; Jonathan Moss; Lawrence Gottlieb; Vesta Valuckaite; Alexander Zaborin; Valeriy Poroyko; Donald C Liu; Olga Zaborina; John C Alverdy
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

4.  Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is μ-opioid receptor-dependent.

Authors:  Jessica M Breslow; Pu Feng; Joseph J Meissler; John E Pintar; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  Microb Pathog       Date:  2010-08-03       Impact factor: 3.738

5.  Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection.

Authors:  Pu Feng; Allan L Truant; Joseph J Meissler; John P Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

Review 6.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

7.  An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P.

Authors:  Xu Wang; Steven D Douglas; Jin-Song Peng; Dun-Jin Zhou; Qi Wan; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 8.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

Review 9.  Opioids and infections in the intensive care unit should clinicians and patients be concerned?

Authors:  Craig R Weinert; Shravan Kethireddy; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-05       Impact factor: 4.147

10.  Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands.

Authors:  Maiwenn J Al; Leona Hakkaart; Siok Swan Tan; Jan Bakker
Journal:  Crit Care       Date:  2010-11-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.